Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jun-24 8:21 PM View:  | Exelixis, Inc. (EXEL) | 31-May-24 | Grant | 18,838 | -- | -- | 1% 1.26M to 1.28M | |
| 22-May-24 7:23 PM View: | Exelixis, Inc. (EXEL) | 20-May-24 | Option Exercise | 11,686 | $19.57 | $228,695.00 | < 1% 1.26M to 1.27M | (7%) |
| 22-May-24 7:23 PM View: | Exelixis, Inc. (EXEL) | 20-May-24 | Private Option Sale | 11,437 | $21.00 | $240,177.00 | (< 1%) 1.27M to 1.26M | |
| 15-Mar-24 4:19 PM View: | Regulus Therapeutics Inc. (RGLS) | 14-Mar-24 | Grant | 250,000 | $1.60 | $400,000.00 | 34% 728.39K to 978.39K | |
| 02-Jun-23 9:13 PM View: | Exelixis, Inc. (EXEL) | 01-Jun-23 | Grant | 20,718 | -- | -- | 2% 1.24M to 1.26M | |
| 14-Apr-23 4:39 PM View: | Regulus Therapeutics Inc. (RGLS) | 13-Apr-23 | Grant | 222,198 | $0.90 | $200,000.00 | 44% 506.19K to 728.39K | |
| 17-Jun-22 5:13 PM View: | Biogen Idec Inc. (BIIB) | 15-Jun-22 | Grant | 2,255 | -- | -- | 6% 36.05K to 38.3K | |
| 27-May-22 9:19 PM View: | Exelixis, Inc. (EXEL) | 26-May-22 | Grant | 19,575 | -- | -- | 2% 1.22M to 1.24M | |
| 24-Feb-22 8:22 PM View: | Exelixis, Inc. (EXEL) | 22-Feb-22 | Private Sale | 84,515 | $19.56 | $1,653,110.00 | (6%) 1.3M to 1.22M | |
| 01-Dec-21 4:12 PM View: | Regulus Therapeutics Inc. (RGLS) | 30-Nov-21 | Grant | 2,222,220 | $0.36 | $800,000.00 | 78% 2.84M to 5.06M | |
| 02-Jul-21 5:27 PM View: | Biogen Idec Inc. (BIIB) | 01-Jul-21 | Grant | 1,275 | -- | -- | 4% 34.77K to 36.05K | |
| 28-May-21 8:26 PM View: | Exelixis, Inc. (EXEL) | 27-May-21 | Grant | 16,424 | -- | -- | 1% 1.29M to 1.3M | |
| 13-May-21 8:32 PM View: | Exelixis, Inc. (EXEL) | 11-May-21 | Option Exercise | 120,000 | $4.27 | $512,400.00 | 10% 1.19M to 1.31M | |
| 13-May-21 8:32 PM View: | Exelixis, Inc. (EXEL) | 11-May-21 | Market Option Sale | 20,770 | $24.98 | $518,794.00 | (2%) 1.31M to 1.29M | |
| 07-Dec-20 4:21 PM View: | Regulus Therapeutics Inc. (RGLS) | 04-Dec-20 | Grant | 793,528 | $0.63 | $500,002.00 | 67% 1.19M to 1.99M | |
| 27-Nov-20 4:05 PM View: | Eucrates Biomedical Acquisi... (EUCR) | 24-Nov-20 | Disposition (other) Duplicate | 255,094 | -- | -- | (9%) 2.88M to 2.62M | |
| 05-Jun-20 5:20 PM View: | Biogen Idec Inc. (BIIB) | 03-Jun-20 | Grant | 1,470 | -- | -- | 4% 33.3K to 34.77K | |
| 22-May-20 9:05 PM View: | Exelixis, Inc. (EXEL) | 21-May-20 | Grant | 15,538 | -- | -- | 1% 1.17M to 1.19M | |
| 15-May-20 8:18 PM View: | Exelixis, Inc. (EXEL) | 13-May-20 | Option Exercise | 120,791 | $5.82 | $703,004.00 | 11% 1.05M to 1.17M | |
| 08-May-20 9:18 PM View: | Exelixis, Inc. (EXEL) | 08-May-20 | Option Exercise | 45,000 | $5.03 | $226,200.00 | 4% 1.05M to 1.1M | |
| 08-May-20 9:18 PM View: | Exelixis, Inc. (EXEL) | 08-May-20 | Market Option Sale | 45,000 | $25.84 | $1,162,800.00 | (4%) 1.1M to 1.05M | |
| 04-Feb-20 4:59 PM View: | Regulus Therapeutics Inc. (RGLS) | 03-Feb-20 | Conversion | 846,320 | -- | -- | 71% 1.19M to 2.04M | |
| 20-Jun-19 5:54 PM View: | Biogen Idec Inc. (BIIB) | 19-Jun-19 | Grant | 1,905 | -- | -- | 6% 31.4K to 33.3K | |
| 24-May-19 8:43 PM View: | Exelixis, Inc. (EXEL) | 23-May-19 | Grant | 10,317 | -- | -- | < 1% 1.04M to 1.05M | |
| 08-May-19 5:13 PM View: | Regulus Therapeutics Inc. (RGLS) | 07-May-19 | Private Purchase | 370,370 | $1.08 | $400,000.00 | 45% 819.5K to 1.19M | |
| 22-Feb-19 7:35 PM View: | Exelixis, Inc. (EXEL) | 21-Feb-19 | Option Exercise | 26,250 | $4.39 | $115,350.00 | 3% 1.04M to 1.07M | |
| 22-Feb-19 7:35 PM View: | Exelixis, Inc. (EXEL) | 21-Feb-19 | Market Option Sale | 26,250 | $21.25 | $557,812.00 | (2%) 1.07M to 1.04M | |
| 02-Jan-19 4:12 PM View: | Regulus Therapeutics Inc. (RGLS) | 28-Dec-18 | Market Purchase | 50,000 | $1.09 | $54,570.00 | 6% 785.07K to 835.07K | 47% |
| 28-Dec-18 4:21 PM View: | Regulus Therapeutics Inc. (RGLS) | 27-Dec-18 | Market Purchase | 26,401 | $1.04 | $27,459.70 | 3% 758.67K to 785.07K | 54% |
| 28-Dec-18 4:21 PM View: | Regulus Therapeutics Inc. (RGLS) | 26-Dec-18 | Market Purchase | 90,000 | $0.95 | $85,878.00 | 13% 668.67K to 758.67K | 68% |
| 19-Nov-18 4:03 PM View: | Regulus Therapeutics Inc. (RGLS) | 16-Nov-18 | Market Purchase | 300,000 | $1.38 | $415,470.00 | 81% 368.67K to 668.67K | 15% |
| 19-Nov-18 4:03 PM View: | Regulus Therapeutics Inc. (RGLS) | 15-Nov-18 | Market Purchase | 200,000 | $1.33 | $265,080.00 | 119% 168.67K to 368.67K | 20% |
| 21-Nov-18 5:29 PM View: | Regulus Therapeutics Inc. (RGLS) | 12-Nov-18 | Grant | 20,910 | -- | -- | 14% 147.76K to 168.67K | |
| 14-Jun-18 5:27 PM View: | Biogen Idec Inc. (BIIB) | 12-Jun-18 | Grant | 1,450 | -- | -- | 5% 29.95K to 31.4K | |
| 24-May-18 8:28 PM View: | Exelixis, Inc. (EXEL) | 24-May-18 | Grant | 7,937 | -- | -- | < 1% 1.03M to 1.04M | |
| 07-May-18 8:07 PM View: | Exelixis, Inc. (EXEL) | 07-May-18 | Option Exercise | 15,000 | $11.66 | $174,900.00 | 1% 1.03M to 1.05M | |
| 07-May-18 8:07 PM View: | Exelixis, Inc. (EXEL) | 07-May-18 | Market Option Sale | 15,000 | $22.15 | $332,250.00 | (1%) 1.05M to 1.03M | |
| 02-Mar-18 8:03 PM View: | Exelixis, Inc. (EXEL) | 02-Mar-18 | Option Exercise | 15,000 | $7.97 | $119,550.00 | 1% 1.03M to 1.05M | |
| 02-Mar-18 8:03 PM View: | Exelixis, Inc. (EXEL) | 02-Mar-18 | Market Option Sale | 15,000 | $24.05 | $360,750.00 | (1%) 1.05M to 1.03M | |
| 06-Dec-17 7:41 PM View: | Regulus Therapeutics Inc. (RGLS) | 04-Dec-17 | Grant | 96,629 | $0.89 | $85,999.80 | 6% 1.7M to 1.8M | (84%) |
| 22-Sep-17 7:07 PM View: | Exelixis, Inc. (EXEL) | 22-Sep-17 | Market Sale | 10,000 | $25.40 | $254,000.00 | (< 1%) 1.04M to 1.03M | 30% |
| 20-Sep-17 6:48 PM View: | Exelixis, Inc. (EXEL) | 19-Sep-17 | Market Sale | 127,790 | $27.63 | $3,530,840.00 | (11%) 1.17M to 1.04M | 36% |
| 20-Sep-17 6:48 PM View: | Exelixis, Inc. (EXEL) | 18-Sep-17 | Market Sale | 72,210 | $27.76 | $2,004,550.00 | (6%) 1.24M to 1.17M | 36% |
| 25-Jul-17 6:06 PM View: | Regulus Therapeutics Inc. (RGLS) | 25-Jul-17 | Private Purchase | 1,000,000 | $0.91 | $910,000.00 | 130% 770.68K to 1.77M | |
| 09-Jun-17 5:52 PM View: | Biogen Idec Inc. (BIIB) | 07-Jun-17 | Grant | 1,740 | -- | -- | 6% 28.21K to 29.95K | |
| 26-May-17 8:49 PM View: | Exelixis, Inc. (EXEL) | 25-May-17 | Grant | 5,843 | -- | -- | < 1% 1.23M to 1.23M | |
| 23-Mar-17 4:26 PM View: | Regulus Therapeutics Inc. (RGLS) | 22-Mar-17 | Market Purchase | 300,000 | $1.23 | $368,100.00 | 75% 400.68K to 700.68K | (88%) |
| 23-Mar-17 4:26 PM View: | Regulus Therapeutics Inc. (RGLS) | 21-Mar-17 | Market Purchase | 200,000 | $1.20 | $239,800.00 | 100% 200.68K to 400.68K | (88%) |
| 21-Mar-17 7:28 PM View: | Exelixis, Inc. (EXEL) | 20-Mar-17 | Option Exercise | 10,000 | $10.53 | $105,300.00 | < 1% 1.24M to 1.25M | |
| 21-Mar-17 7:28 PM View: | Exelixis, Inc. (EXEL) | 20-Mar-17 | Market Option Sale | 10,000 | $21.66 | $216,600.00 | (< 1%) 1.25M to 1.24M | 18% |